首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Impact of heparin-binding domain of recombinant human osteocalcin-fibronectinIII9-14 on the osteoblastic cell response
Authors:Ye-Rang Yun  Hae-Won Kim  Jun-Hyeog Jang
Institution:1. Institute of Tissue Regeneration Engineering (ITREN), Dankook University, Cheonan, 330-714, South Korea
2. Department of Nanobiomedical Science and WCU Research Center, Dankook University Graduate School, Cheonan, 330-714, South Korea
3. Department of Biomaterials Science, School of Dentistry, Dankook University, Cheonan, 330-714, South Korea
4. Department of Biochemistry, Inha University School of Medicine, Inchon, 400-712, South Korea
Abstract:Fibronectin (FN) containing a heparin-binding domain (HBD) and an Arg-Gly-Asp (RGD) domain can promote cell adhesion and proliferation compared to FN that contained only RGD. Here, we have engineered recombinant human osteocalcin (rhOC) with FN type III9-14 (rhOC-FNIII9-14) containing RGD and HBD to promote the cellular activity of MC3T3-E1 cells, including adhesion, proliferation, and differentiation. RhOC-FNIII9-14 significantly increased cell adhesion and proliferation of MC3T3-E1 cells compared to rhOC-FNIII9-10 (P < 0.05). Moreover, rhOC-FNIII9-14 showed osteogenic differentiation of MC3T3-E1 cells in mineralization activity and osteogenic gene expression.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号